1-3 of 3
Christoph Biermann
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Osteopontin is a prognostic factor for survival of acute myeloid leukemia patients

Ruediger Liersch, Joachim Gerss, Christoph Schliemann, Michael Bayer, Christian Schwöppe, Christoph Biermann, Iris Appelmann, Torsten Kessler, Bob Löwenberg, Thomas Büchner, Wolfgang Hiddemann, Carsten Müller-Tidow, Wolfgang E. Berdel, Rolf Mesters
Journal: Blood
Blood (2012) 119 (22): 5215–5220.
https://doi.org/10.1182/blood-2011-11-389692
Published: 2012
Includes: Supplemental data
Journal Articles

Expression of Osteopontin in the Bone Marrow of Patients with Acute Myeloid Leukemia.

Ruediger Liersch, MD, Michael Bayer, Christoph Biermann, Iris Appelmann, Christoph Schliemann, MD, Christian Schwoeppe, Torsten Kessler, MD, Carsten Mueller-Tidow, MD, Wolfgang Berdel, Rolf Mesters
Journal: Blood
Blood (2009) 114 (22): 4694.
https://doi.org/10.1182/blood.V114.22.4694.4694
Published: 2009
Journal Articles

Constitutive Activation of Akt and mTOR by Flt3 Internal Tandem Duplications Mediates Myeloid Leukemogenesis and Can Be Inhibited by Rapamycin.

Christian H. Brandts, MD, Bulent Sargin, MD, Miriam Rode, MS, Christoph Biermann, Beate Lindtner, Joachim Schwable, MD, Horst Buerger, MD, Carsten Muller-Tidow, MD, Chunaram Choudhary, Martin McMahon, PhD, Wolfgang E. Berdel, MD, Hubert L. Serve, MD
Journal: Blood
Blood (2004) 104 (11): 2532.
https://doi.org/10.1182/blood.V104.11.2532.2532
Published: 2004